Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.040
+0.190 (6.67%)
At close: Aug 13, 2025, 4:00 PM
3.000
-0.040 (-1.32%)
Pre-market: Aug 14, 2025, 9:08 AM EDT
Evaxion Employees
Evaxion had 46 employees as of December 31, 2024. The number of employees decreased by 3 or -6.12% compared to the previous year.
Employees
46
Change (1Y)
-3
Growth (1Y)
-6.12%
Revenue / Employee
$71,587
Profits / Employee
-$290,022
Market Cap
19.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
EVAX News
- 3 days ago - Evaxion to announce business update and second quarter 2025 financial results on August 14, 2025 - GlobeNewsWire
- 20 days ago - Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025 - GlobeNewsWire
- 4 weeks ago - Evaxion finalizes agreement with EIB to convert debt into equity - GlobeNewsWire
- 6 weeks ago - Evaxion announces changes to Executive Management to optimize the value of proprietary AI-Immunology™ platform and portfolio - GlobeNewsWire
- 7 weeks ago - Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus - GlobeNewsWire
- 2 months ago - Evaxion receives grant funding to design new polio vaccine - GlobeNewsWire
- 2 months ago - Evaxion Biotech A/S (EVAX) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Evaxion announces business update and first quarter 2025 financial results - GlobeNewsWire